Dumfries & Galloway Health Board
Prescribing Support Team

Review of MR Dipyridamole for secondary prevention of occlusive events in patients with a history of ischaemic stroke or TIA

Posted: 30 Apr 12 Edited: 13 Aug 18
Audits Cardiovascular

This audit protocol supports the review of patients who are taking Dipyridamole MR for the secondary prevention of occlusive events following ischaemic stroke, TIA or amaurosis fugax.

Open
Explore
Dumfries & Galloway Prescribing Support Team

The site has been created to act as a central resource for all local drug advice as approved by Dumfries & Galloway Health Boards' Area Drug and Therapeutics Committee.

The ready access to prescribing information will support the safe and cost effective use of drugs in Dumfries & Galloway.

At present we spend £49million on drugs annually; it is therefore imperative that we maximise the health benefits from this investment for the people of Dumfries & Galloway through the use of evidence based medicine.

Copyright © 2015-2024 Dumfries & Galloway Prescribing Support Team. All Rights Reserved.
Primary Care Development · Crichton Hall · Bankend Road · Dumfries · United Kingdom · DG1 4TG
Telephone: 01776 707707 | 07825 888986 · E-mail: info@dgprescribingmatters.co.uk

© Website by NJ